Global Botulinum Neurotoxins Market Insights, Forecast to 2025

Description

The global Botulinum Neurotoxins market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Botulinum Neurotoxins market based on company, product type, end user and key regions.

This report studies the global market size of Botulinum Neurotoxins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Botulinum Neurotoxins in these regions.
This research report categorizes the global Botulinum Neurotoxins market by top players/brands, region, type and end user. This report also studies the global Botulinum Neurotoxins market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG

Market size by Product
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
Market size by End User
Medical Uses
Cosmetics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Botulinum Neurotoxins market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Botulinum Neurotoxins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Botulinum Neurotoxins companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Botulinum Neurotoxins submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Botulinum Neurotoxins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Botulinum Neurotoxins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Botulinum Neurotoxins Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Botulinum Neurotoxins Market Size Growth Rate by Product
1.4.2 Botulinum Neurotoxins A (BoNT/A)
1.4.3 Botulinum Neurotoxins B (BoNT/B)
1.4.4 Botulinum Neurotoxins E (BoNT/E)
1.4.5 Botulinum Neurotoxins F (BoNT/F)
1.4.6 Botulinum Neurotoxins C (BoNT/C)
1.4.7 Botulinum Neurotoxins D (BoNT/D)
1.4.8 Botulinum Neurotoxins G (BoNT/G)
1.5 Market by End User
1.5.1 Global Botulinum Neurotoxins Market Size Growth Rate by End User
1.5.2 Medical Uses
1.5.3 Cosmetics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Botulinum Neurotoxins Market Size
2.1.1 Global Botulinum Neurotoxins Revenue 2014-2025
2.1.2 Global Botulinum Neurotoxins Sales 2014-2025
2.2 Botulinum Neurotoxins Growth Rate by Regions
2.2.1 Global Botulinum Neurotoxins Sales by Regions
2.2.2 Global Botulinum Neurotoxins Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Botulinum Neurotoxins Sales by Manufacturers
3.1.1 Botulinum Neurotoxins Sales by Manufacturers
3.1.2 Botulinum Neurotoxins Sales Market Share by Manufacturers
3.1.3 Global Botulinum Neurotoxins Market Concentration Ratio (CR5 and HHI)
3.2 Botulinum Neurotoxins Revenue by Manufacturers
3.2.1 Botulinum Neurotoxins Revenue by Manufacturers (2014-2019)
3.2.2 Botulinum Neurotoxins Revenue Share by Manufacturers (2014-2019)
3.3 Botulinum Neurotoxins Price by Manufacturers
3.4 Botulinum Neurotoxins Manufacturing Base Distribution, Product Types
3.4.1 Botulinum Neurotoxins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Botulinum Neurotoxins Product Type
3.4.3 Date of International Manufacturers Enter into Botulinum Neurotoxins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Botulinum Neurotoxins Sales by Product
4.2 Global Botulinum Neurotoxins Revenue by Product
4.3 Botulinum Neurotoxins Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Botulinum Neurotoxins Breakdown Data by End User

6 North America
6.1 North America Botulinum Neurotoxins by Countries
6.1.1 North America Botulinum Neurotoxins Sales by Countries
6.1.2 North America Botulinum Neurotoxins Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Botulinum Neurotoxins by Product
6.3 North America Botulinum Neurotoxins by End User

7 Europe
7.1 Europe Botulinum Neurotoxins by Countries
7.1.1 Europe Botulinum Neurotoxins Sales by Countries
7.1.2 Europe Botulinum Neurotoxins Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Botulinum Neurotoxins by Product
7.3 Europe Botulinum Neurotoxins by End User

8 Asia Pacific
8.1 Asia Pacific Botulinum Neurotoxins by Countries
8.1.1 Asia Pacific Botulinum Neurotoxins Sales by Countries
8.1.2 Asia Pacific Botulinum Neurotoxins Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Botulinum Neurotoxins by Product
8.3 Asia Pacific Botulinum Neurotoxins by End User

9 Central & South America
9.1 Central & South America Botulinum Neurotoxins by Countries
9.1.1 Central & South America Botulinum Neurotoxins Sales by Countries
9.1.2 Central & South America Botulinum Neurotoxins Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Botulinum Neurotoxins by Product
9.3 Central & South America Botulinum Neurotoxins by End User

10 Middle East and Africa
10.1 Middle East and Africa Botulinum Neurotoxins by Countries
10.1.1 Middle East and Africa Botulinum Neurotoxins Sales by Countries
10.1.2 Middle East and Africa Botulinum Neurotoxins Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Botulinum Neurotoxins by Product
10.3 Middle East and Africa Botulinum Neurotoxins by End User

11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Company Business Overview
11.1.3 Johnson & Johnson Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Johnson & Johnson Botulinum Neurotoxins Products Offered
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GSK Botulinum Neurotoxins Products Offered
11.2.5 GSK Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Company Business Overview
11.3.3 Allergan Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Allergan Botulinum Neurotoxins Products Offered
11.3.5 Allergan Recent Development
11.4 Chong Kun Dang
11.4.1 Chong Kun Dang Company Details
11.4.2 Company Business Overview
11.4.3 Chong Kun Dang Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Chong Kun Dang Botulinum Neurotoxins Products Offered
11.4.5 Chong Kun Dang Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Company Business Overview
11.5.3 Eisai Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eisai Botulinum Neurotoxins Products Offered
11.5.5 Eisai Recent Development
11.6 Nestle
11.6.1 Nestle Company Details
11.6.2 Company Business Overview
11.6.3 Nestle Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Nestle Botulinum Neurotoxins Products Offered
11.6.5 Nestle Recent Development
11.7 Galderma
11.7.1 Galderma Company Details
11.7.2 Company Business Overview
11.7.3 Galderma Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Galderma Botulinum Neurotoxins Products Offered
11.7.5 Galderma Recent Development
11.8 Ipsen
11.8.1 Ipsen Company Details
11.8.2 Company Business Overview
11.8.3 Ipsen Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Ipsen Botulinum Neurotoxins Products Offered
11.8.5 Ipsen Recent Development
11.9 Hugel
11.9.1 Hugel Company Details
11.9.2 Company Business Overview
11.9.3 Hugel Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Hugel Botulinum Neurotoxins Products Offered
11.9.5 Hugel Recent Development
11.10 Mentor
11.10.1 Mentor Company Details
11.10.2 Company Business Overview
11.10.3 Mentor Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mentor Botulinum Neurotoxins Products Offered
11.10.5 Mentor Recent Development
11.11 CROMA
11.12 Alphaeon
11.13 OBI Pharma
11.14 Revance Therapeutics
11.15 Daewoong Pharmaceutical
11.16 Medy-Tox
11.17 EpiVax
11.18 Anterios
11.19 Escape Therapeutics
11.20 Lipella
11.21 Malvern Cosmeceutics
11.22 PharmaVital
11.23 Merz Pharma
11.24 Transdermal
11.25 Valeant Pharmaceuticals
11.26 CNBG

12 Future Forecast
12.1 Botulinum Neurotoxins Market Forecast by Regions
12.1.1 Global Botulinum Neurotoxins Sales Forecast by Regions 2019-2025
12.1.2 Global Botulinum Neurotoxins Revenue Forecast by Regions 2019-2025
12.2 Botulinum Neurotoxins Market Forecast by Product
12.2.1 Global Botulinum Neurotoxins Sales Forecast by Product 2019-2025
12.2.2 Global Botulinum Neurotoxins Revenue Forecast by Product 2019-2025
12.3 Botulinum Neurotoxins Market Forecast by End User
12.4 North America Botulinum Neurotoxins Forecast
12.5 Europe Botulinum Neurotoxins Forecast
12.6 Asia Pacific Botulinum Neurotoxins Forecast
12.7 Central & South America Botulinum Neurotoxins Forecast
12.8 Middle East and Africa Botulinum Neurotoxins Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Botulinum Neurotoxins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample